Metraipolis › archive › dc_aa2228bcb9a2

Efgartigimod as a salvage therapy for anti-NMDAR encephalitis patients after first-line treatment failure: a case series — Europe PMC PMID:42666164

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42666164
DOI
10.3389/fneur.2026.1842709
License (as archived)
solo-consultazione
Archived
2026-10-08T07:21:03.546Z
SHA-256 of the archived text
f08c3b712f5ab33fe695185dea44d7660d3b9b89059b0c92033e140b75d6a12b
Stable URL of this page
https://metraipolis.com/documento/dc_aa2228bcb9a2

How to cite

Efgartigimod as a salvage therapy for anti-NMDAR encephalitis patients after first-line treatment failure: a case series — Europe PMC PMID:42666164 — Europe PMC (en), https://europepmc.org/article/MED/42666164 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa2228bcb9a2 (Metraipolis archive dc_aa2228bcb9a2, sha256 f08c3b712f5ab33fe695185dea44d7660d3b9b89059b0c92033e140b75d6a12b)
BibTeX
@misc{dcaa2228bcb9a2,
  title = {Efgartigimod as a salvage therapy for anti-NMDAR encephalitis patients after first-line treatment failure: a case series — Europe PMC PMID:42666164},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42666164},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa2228bcb9a2; sha256 f08c3b712f5ab33fe695185dea44d7660d3b9b89059b0c92033e140b75d6a12b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42666164. Agents can read the archived copy with the MCP tool read_document.